Literature DB >> 32976055

Impending Central Retinal Vein Occlusion in a Patient with Coronavirus Disease 2019 (COVID-19).

Alessandro Invernizzi1,2, Marco Pellegrini1, Dario Messenio1, Matteo Cereda1, Pietro Olivieri3, Anna Maria Brambilla4, Giovanni Staurenghi1.   

Abstract

PURPOSE: To report a case of impending central retinal vein occlusion (iCRVO) in a COVID-19 patient. CASE REPORT: A 54 years old woman with COVID-19 related pneumonia presented to our emergency department complaining of scotomas and decreased vision in her right eye. Funduscopic examination and multimodal imaging revealed rare retinal hemorrhages, retinal whitening, and fern-like hypo-autofluorescent appearance typical of iCRVO. She had no risk factors other than a transient hyper-coagulability status likely related to the ongoing infection. Systemic treatment with steroids normalized her inflammatory and coagulation status and the occlusion completely resolved.
CONCLUSIONS: Retinal circulation should be considered as a potential site for thromboembolic complications from COVID-19.

Entities:  

Keywords:  Covid-19; Retina; SARS-CoV-2; thrombosis; vein occlusion

Mesh:

Year:  2020        PMID: 32976055     DOI: 10.1080/09273948.2020.1807023

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  20 in total

1.  Branch Retinal Vein Occlusion in a COVID-19 Positive Patient.

Authors:  Sarah Madison Duff; Matthew Wilde; Gibran Khurshid
Journal:  Cureus       Date:  2021-02-27

2.  Evaluation of choroidal thickness with OCT in COVID-19 patients with high D-dimer levels.

Authors:  Fatih Cem Gül; Esra Suay Timurkaan
Journal:  Sci Rep       Date:  2022-10-18       Impact factor: 4.996

3.  Coronavirus-19-Associated Retinopathy.

Authors:  Christopher D Conrady; Lisa J Faia; Kevin S Gregg; Rajesh C Rao
Journal:  Ocul Immunol Inflamm       Date:  2021-04-15       Impact factor: 3.070

4.  Reduced macular vessel density in COVID-19 patients with and without associated thrombotic events using optical coherence tomography angiography.

Authors:  Noemi Guemes-Villahoz; Barbara Burgos-Blasco; Beatriz Vidal-Villegas; Juan Donate-López; María Herrera de la Muela; Lorenzo López-Guajardo; Francisco Javier Martín-Sánchez; Julián García-Feijoó
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-07       Impact factor: 3.117

Review 5.  Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review.

Authors:  Giuliano Lo Bianco; Santi Di Pietro; Emilia Mazzuca; Aurelio Imburgia; Luca Tarantino; Giuseppe Accurso; Vincenzo Benenati; Federica Vernuccio; Claudio Bucolo; Salvatore Salomone; Marianna Riolo
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

Review 6.  Evidence of SARS-CoV-2 Transmission Through the Ocular Route.

Authors:  Jing-Yu Qu; Hua-Tao Xie; Ming-Chang Zhang
Journal:  Clin Ophthalmol       Date:  2021-02-18

Review 7.  The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.

Authors:  Koji Kitazawa; Stefanie Deinhardt-Emmer; Takenori Inomata; Sharvari Deshpande; Chie Sotozono
Journal:  Cells       Date:  2021-04-02       Impact factor: 6.600

8.  Central retinal vein occlusion in the setting of COVID-19 infection.

Authors:  Nilesh Raval; Anna Djougarian; James Lin
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-04-02

9.  How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group.

Authors:  Francesca Ferretti; Rosanna Cannatelli; Maurizio Benucci; Stefania Carmagnola; Emilio Clementi; Piergiorgio Danelli; Dario Dilillo; Paolo Fiorina; Massimo Galli; Maurizio Gallieni; Giovanni Genovese; Valeria Giorgi; Alessandro Invernizzi; Giovanni Maconi; Jeanette A Maier; Angelo V Marzano; Paola S Morpurgo; Manuela Nebuloni; Dejan Radovanovic; Agostino Riva; Giuliano Rizzardini; Gianmarco Sabiu; Pierachille Santus; Giovanni Staurenghi; Gianvincenzo Zuccotti; Pier Carlo Sarzi-Puttini; Sandro Ardizzone
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

10.  [Effects of the COVID-19 pandemic on a cohort of patients with vein occlusion].

Authors:  J D García Palacios; N Puente Ruiz; J J Napal Lecumberri; J L Hernández Hernández
Journal:  Rev Clin Esp       Date:  2021-06-18       Impact factor: 1.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.